COMPLEXA INC.
Profile
Company Names
COMPLEXA INC.
Addresses
1055 WESTLAKES DRIVE, SUITE 200, BERWYN, PA 19312
170 NORTH RADNOR CHESTER ROAD, SUITE 350, RADNOR, PA 19087
2425 SIDNEY STREET, PITTSBURGH, PA 15203
Phone Numbers
484-329-8436
412-727-8727
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$78,903,625.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2019-04-08
$10,999,999.00
$28,000,000.00
$17,000,001.00
Equity
8
2017-07-14
$40,570,421.00
$62,570,421.00
$22,000,000.00
Equity
7
2016-11-23
$1,000,000.00
$1,400,000.00
$400,000.00
Debt
6
2016-03-24
$950,000.00
$2,000,000.00
$1,050,000.00
Debt
5
2015-06-05
$4,000,000.00
$5,000,000.00
$1,000,000.00
Debt
4
2014-05-30
$14,765,747.00
$14,765,747.00
$0.00
Equity
3
2013-10-10
$3,175,000.00
$4,400,000.00
$1,225,000.00
Debt
2
2013-04-23
$1,400,000.00
$1,400,000.00
$0.00
Debt
1
2012-05-23
$2,042,458.00
$3,624,187.00
$1,581,729.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BARBARA
DALTON
DIRECTOR
HIRONORI
HOZOJI
DIRECTOR
CARTER
MEYER
DIRECTOR
CURE DM INC
| ANTERIOS INC
| EMKINETICS INC
| SCIENTIFIC HEALTH DEVELOPMENT II, LTD.
| SIGHT SCIENCES, INC.
| LIVEPROCESS CORP
| COMPLEXA INC.
| CHANNEL MEDSYSTEMS, INC.
| AZEVAN PHARMACEUTICALS INC
| POTRERO MEDICAL, INC.
| ESCULON, INC.
| PODIMETRICS, INC.
| RIVERMARK MEDICAL, INC.
| ARTELON, INC.
| LHOTSE MEDICAL, INC.
| BRIUS TECHNOLOGIES, INC.
| SPIRAIR, INC.
I.
WISTAR
MORRIS
DIRECTOR
DAVID
MOTT
DIRECTOR
3-V BIOSCIENCES, INC.
| TESARO, INC.
| ARDELYX, INC.
| ZYNGENIA, INC.
| OMTHERA PHARMACEUTICALS, INC.
| MERSANA THERAPEUTICS INC
| CYDAN, LLC
| EDIMER PHARMACEUTICALS, INC.
| PROSENSA HOLDING N.V.
| ADAPTIMMUNE LTD
| MERSANA THERAPEUTICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| IMARA INC.
| COMPLEXA INC.
| CYDAN II, INC.
| TIBURIO THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
